A publication concerning anamorelin appeared on August 22, 2026, in the journal Current Medicinal Chemistry. The article is titled "Exploring Inhibitory Impacts of Anamorelin on Colorectal Cancer Proliferation via Regulation of Transketolase." It is indexed under PubMed ID 42693844. This entry reflects a new addition to the scientific literature on anamorelin, a compound currently classified as unapproved and under research investigation. The publication's title indicates its subject matter relates to colorectal cancer proliferation and transketolase regulation. No findings, conclusions, or efficacy data from the study are being reported here, as only the publication event itself is confirmed. Readers interested in the underlying research should consult the original article via the source link for full methodological and results details. This brief serves only to note the publication's existence in the scientific record. For additional background on anamorelin, including its research status and other available data, readers can refer to the compound overview.
New Publication: Anamorelin Study on Colorectal Cancer Proliferation
See the full anamorelin overview
Source: https://pubmed.ncbi.nlm.nih.gov/42693844/